Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2024-06-20

Investigation of metabolic processes underlying brain myelination defects using magnetic resonance spectroscopy of oligodendrocyte extracts

Objective

Genetic factors are responsible for many degenerative diseases of the nervous system. Proteolipid protein (PLP), the most abundant myelin protein of the central nervous system (CNS), is positioned in compact myelin, and alterations in the processing of PLP are a major cause in inherited diseases of CNS myelin. For instance, the Pelizaeus Merzbacher disease is a disorder of the central nervous myelination, caused in most cases by mutations involving the PLP gene.

It has been known for several years that myelin formation in the mammalian CNS is closely related to the oligodendrocyte population, and that the latter may be regulated by apoptosis. It is also known that PLP mutations resulting in demyelination lead to extended oligodendrocyte apoptosis. The proposed research aim is to investigate metabolic processes underlying myelination defects in the CNS.

Fields of science (EuroSciVoc)

Keywords

Topic(s)

Call for proposal

FP6-2002-MOBILITY-12
See other projects for this call

Funding Scheme

IRG - Marie Curie actions-International re-integration grants

Coordinator

UNIVERSITE LOUIS PASTEUR
EU contribution
No data
Address


France
Total cost
No data